Update: 06.02.2023
Last week: 4 week 2023 (23.01.2023 - 29.01.2023)
Last full month: December 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 111 902 | 0.7% | 2.8% | 0.1 | 30 558 186 | 0.6% | 3.6% | 0.1 | -2.2% |
| MoM | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| YTD | 468 934 | -65.8% | 2.8% | -3.5 | 126 617 828 | -51.0% | 3.5% | -2.6 | -22.8% |
| MAT | 8 944 384 | -36.6% | 4.4% | -2.1 | 1 888 214 308 | -23.1% | 4.4% | -1.5 | -6.7% |
| DEXALGIN | |||||||||
| WoW | 19 909 | -2.4% | 0.4% | 0 | 10 643 754 | -1.5% | 1.4% | 0 | -1.5% |
| MoM | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| YTD | 78 500 | -57.1% | 0.4% | -0.4 | 41 602 699 | -41.4% | 1.4% | -0.9 | -14.4% |
| MAT | 1 480 989 | -21.7% | 0.6% | -0.1 | 657 312 624 | -9.1% | 1.6% | -0.3 | -2.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 358 | -11.0% | 37.2% | -4.2 | 33 972 041 | -12.3% | 47.9% | -4.6 | -1.0% |
| MoM | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| YTD | 205 502 | -53.5% | 39.5% | -22.1 | 133 697 534 | -36.4% | 50.6% | -17.7 | -27.4% |
| MAT | 4 047 547 | -23.9% | 51.4% | -14.1 | 2 131 951 353 | -13.4% | 57.5% | -12.7 | -3.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 754 | -2.7% | 30.6% | 0.9 | 16 450 981 | -2.9% | 48.6% | 1.3 | -5.4% |
| MoM | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| YTD | 80 648 | -37.6% | 29.7% | -10 | 62 992 774 | -17.0% | 46.7% | -7.5 | -16.4% |
| MAT | 1 377 640 | -16.7% | 36.2% | -4.9 | 892 638 446 | -7.8% | 49.8% | -6.1 | -5.3% |
| FASTUM | |||||||||
| WoW | 15 925 | 0.9% | 0.9% | 0 | 9 841 450 | 0.6% | 2.7% | 0.1 | -2.2% |
| MoM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| YTD | 62 200 | -47.9% | 1.0% | -0.6 | 38 361 884 | -31.3% | 2.7% | -0.9 | -13.4% |
| MAT | 983 404 | -29.2% | 1.0% | -0.4 | 528 853 768 | -18.0% | 2.4% | -0.7 | -1.4% |
| IODOMARIN | |||||||||
| WoW | 65 214 | 3.4% | 21.6% | 1.1 | 12 126 726 | 4.1% | 8.5% | 0.7 | -1.9% |
| MoM | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| YTD | 230 523 | -19.5% | 20.8% | -1.8 | 42 625 076 | -17.8% | 7.9% | -1.9 | -12.6% |
| MAT | 3 237 606 | -0.2% | 20.4% | -0.5 | 630 795 632 | 4.8% | 8.9% | -0.5 | 2.2% |
| LIOTON | |||||||||
| WoW | 16 058 | 20.0% | 1.8% | 0.3 | 20 676 678 | 24.9% | 4.9% | 1.1 | -0.8% |
| MoM | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| YTD | 52 495 | -51.2% | 1.5% | -1.1 | 64 944 411 | -31.3% | 4.0% | -1.6 | -17.4% |
| MAT | 1 196 427 | -29.4% | 2.1% | -0.6 | 1 277 801 413 | -9.8% | 4.5% | -1.1 | -8.7% |
| MEZYM | |||||||||
| WoW | 220 143 | -3.1% | 19.2% | 0.3 | 34 683 943 | -2.6% | 13.3% | 0.2 | -4.8% |
| MoM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| YTD | 905 064 | -54.2% | 19.5% | -12.1 | 140 572 185 | -49.1% | 13.4% | -10 | -25.9% |
| MAT | 16 278 896 | -23.2% | 24.4% | -5 | 2 508 696 099 | -15.6% | 17.3% | -4.7 | -7.3% |
| MIG 400 | |||||||||
| WoW | 110 003 | -8.2% | 2.2% | -0.2 | 14 001 590 | -8.0% | 1.8% | -0.1 | -1.5% |
| MoM | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| YTD | 444 119 | -40.9% | 2.3% | -1 | 57 012 648 | -34.0% | 1.9% | -0.9 | -14.4% |
| MAT | 8 088 660 | -20.4% | 3.1% | -0.7 | 964 777 180 | -16.1% | 2.4% | -0.7 | -2.6% |
| PROSTAMOL | |||||||||
| WoW | 21 225 | -6.5% | 13.4% | -0.7 | 32 042 635 | -6.4% | 15.1% | -1 | -1.8% |
| MoM | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| YTD | 83 554 | -50.1% | 13.9% | -9.8 | 125 358 064 | -42.9% | 15.8% | -9.6 | -15.0% |
| MAT | 1 462 622 | -31.2% | 17.4% | -7.1 | 2 070 776 359 | -23.2% | 18.6% | -7.9 | -3.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 21 532 | -6.9% | 6.6% | -0.6 | 12 294 208 | -7.5% | 7.7% | -0.8 | 1.5% |
| MoM | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
| YTD | 92 194 | -36.6% | 7.2% | -2.7 | 52 287 293 | -17.5% | 8.4% | -1.1 | -13.0% |
| MAT | 1 248 357 | 42.2% | 8.1% | 2.3 | 612 457 575 | 52.5% | 8.4% | 2.4 | 1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 468 934 | -65.8% | 2.8% | -3.5 | 126 617 828 | -51.0% | 3.5% | -2.6 | -22.8% |
| DEXALGIN | 78 500 | -57.1% | 0.4% | -0.4 | 41 602 699 | -41.4% | 1.4% | -0.9 | -14.4% |
| ESPUMISAN (ADULTS) | 205 502 | -53.5% | 39.5% | -22.1 | 133 697 534 | -36.4% | 50.6% | -17.7 | -27.4% |
| ESPUMISAN BABY | 80 648 | -37.6% | 29.7% | -10 | 62 992 774 | -17.0% | 46.7% | -7.5 | -16.4% |
| FASTUM | 62 200 | -47.9% | 1.0% | -0.6 | 38 361 884 | -31.3% | 2.7% | -0.9 | -13.4% |
| IODOMARIN | 230 523 | -19.5% | 20.8% | -1.8 | 42 625 076 | -17.8% | 7.9% | -1.9 | -12.6% |
| LIOTON | 52 495 | -51.2% | 1.5% | -1.1 | 64 944 411 | -31.3% | 4.0% | -1.6 | -17.4% |
| MEZYM | 905 064 | -54.2% | 19.5% | -12.1 | 140 572 185 | -49.1% | 13.4% | -10 | -25.9% |
| MIG 400 | 444 119 | -40.9% | 2.3% | -1 | 57 012 648 | -34.0% | 1.9% | -0.9 | -14.4% |
| PROSTAMOL | 83 554 | -50.1% | 13.9% | -9.8 | 125 358 064 | -42.9% | 15.8% | -9.6 | -15.0% |
| RESPERO MYRTOL | 92 194 | -36.6% | 7.2% | -2.7 | 52 287 293 | -17.5% | 8.4% | -1.1 | -13.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 944 384 | -36.6% | 4.4% | -2.1 | 1 888 214 308 | -23.1% | 4.4% | -1.5 | -6.7% |
| DEXALGIN | 1 480 989 | -21.7% | 0.6% | -0.1 | 657 312 624 | -9.1% | 1.6% | -0.3 | -2.6% |
| ESPUMISAN (ADULTS) | 4 047 547 | -23.9% | 51.4% | -14.1 | 2 131 951 353 | -13.4% | 57.5% | -12.7 | -3.1% |
| ESPUMISAN BABY | 1 377 640 | -16.7% | 36.2% | -4.9 | 892 638 446 | -7.8% | 49.8% | -6.1 | -5.3% |
| FASTUM | 983 404 | -29.2% | 1.0% | -0.4 | 528 853 768 | -18.0% | 2.4% | -0.7 | -1.4% |
| IODOMARIN | 3 237 606 | -0.2% | 20.4% | -0.5 | 630 795 632 | 4.8% | 8.9% | -0.5 | 2.2% |
| LIOTON | 1 196 427 | -29.4% | 2.1% | -0.6 | 1 277 801 413 | -9.8% | 4.5% | -1.1 | -8.7% |
| MEZYM | 16 278 896 | -23.2% | 24.4% | -5 | 2 508 696 099 | -15.6% | 17.3% | -4.7 | -7.3% |
| MIG 400 | 8 088 660 | -20.4% | 3.1% | -0.7 | 964 777 180 | -16.1% | 2.4% | -0.7 | -2.6% |
| PROSTAMOL | 1 462 622 | -31.2% | 17.4% | -7.1 | 2 070 776 359 | -23.2% | 18.6% | -7.9 | -3.2% |
| RESPERO MYRTOL | 1 248 357 | 42.2% | 8.1% | 2.3 | 612 457 575 | 52.5% | 8.4% | 2.4 | 1.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 111 902 | 0.7% | 2.8% | 0.1 | 30 558 186 | 0.6% | 3.6% | 0.1 | -2.2% |
| DEXALGIN | 19 909 | -2.4% | 0.4% | 0 | 10 643 754 | -1.5% | 1.4% | 0 | -1.5% |
| ESPUMISAN (ADULTS) | 52 358 | -11.0% | 37.2% | -4.2 | 33 972 041 | -12.3% | 47.9% | -4.6 | -1.0% |
| ESPUMISAN BABY | 20 754 | -2.7% | 30.6% | 0.9 | 16 450 981 | -2.9% | 48.6% | 1.3 | -5.4% |
| FASTUM | 15 925 | 0.9% | 0.9% | 0 | 9 841 450 | 0.6% | 2.7% | 0.1 | -2.2% |
| IODOMARIN | 65 214 | 3.4% | 21.6% | 1.1 | 12 126 726 | 4.1% | 8.5% | 0.7 | -1.9% |
| LIOTON | 16 058 | 20.0% | 1.8% | 0.3 | 20 676 678 | 24.9% | 4.9% | 1.1 | -0.8% |
| MEZYM | 220 143 | -3.1% | 19.2% | 0.3 | 34 683 943 | -2.6% | 13.3% | 0.2 | -4.8% |
| MIG 400 | 110 003 | -8.2% | 2.2% | -0.2 | 14 001 590 | -8.0% | 1.8% | -0.1 | -1.5% |
| PROSTAMOL | 21 225 | -6.5% | 13.4% | -0.7 | 32 042 635 | -6.4% | 15.1% | -1 | -1.8% |
| RESPERO MYRTOL | 21 532 | -6.9% | 6.6% | -0.6 | 12 294 208 | -7.5% | 7.7% | -0.8 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| DEXALGIN | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| ESPUMISAN (ADULTS) | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| ESPUMISAN BABY | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| FASTUM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| IODOMARIN | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| LIOTON | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| MEZYM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| MIG 400 | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| PROSTAMOL | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| RESPERO MYRTOL | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs